A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark (Q39321463)

11 September 2017

title

A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark (English)

1 reference

11 September 2017

0 references

0 references

1 reference

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27705031 AND SRC:MED&resulttype=core&format=json

1 June 2020

author name string

C K Tikkanen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27705031 AND SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

5 October 2016

1 reference

Journal of Medical Economics

11 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27705031 AND SRC:MED&resulttype=core&format=json

1 June 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27705031 AND SRC:MED&resulttype=core&format=json

1 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27705031 AND SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

213-220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27705031 AND SRC:MED&resulttype=core&format=json

Societal costs of diabetes mellitus in Denmark.

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

A review of the pharmacological properties of insulin degludec and their clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in i

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Efficacy and safety of once-daily insulin degludec dosed flexibly at convenient times vs fixed dosing at the same time each day in a Japanese cohort with type 2 diabetes: A randomized, 26-week, treat-to-target trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Insulin degludec versus insulin glargine in type 1 and type 2 diabetes mellitus: a meta-analysis of endpoints in phase 3a trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Evaluation of the cost-utility of insulin degludec vs insulin glargine in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Self-reported non-severe hypoglycaemic events in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Incidence and cost of hypoglycemic events requiring medical assistance in a hospital setting in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Prehospital management of diabetic emergencies – a population‐based intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Insulin degludec once-daily in type 2 diabetes: simple or step-wise titration (BEGIN: once simple use).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Preoperative Cognitive-Behavioral Patient Education Versus Standard Care for Lumbar Spinal Fusion Patients: Economic Evaluation Alongside a Randomized Controlled Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Health economic evaluation of single-lead atrial pacing vs. dual-chamber pacing in sick sinus syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

Analysis of cost effectiveness of screening Danish men aged 65 for abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13696998.2016.1245663

10.1080/13696998.2016.1245663

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27705031 AND SRC:MED&resulttype=core&format=json

release_ur5dkvadwzepdb7s22m3ucw4le

1 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ur5dkvadwzepdb7s22m3ucw4le

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference